GlassScriptPhysician profile
Steven D Lasser
NPI 1750302048
$6,630.67
in general payments reported to CMS, 2019-2025
16 companies · $904 in 2025
The $904 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $1,859 · 2021: $555 · 2022: $990 · 2023: $728 · 2024: $899 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,370 · Education: $137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,369.59 |
| Education | $137.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,377.38 | 2019-2025 | Cascadia Interbody System, Niagara Lateral Access System, Prolift |
| Medical Device Business Services, INC. | $502.32 | 2023-2024 | |
| Kerecis Limited | $397.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heron Therapeutics, INC. | $218.64 | 2023-2025 | Zynrelef, Aponvie |
| Atricure, INC. | $165.83 | 2024 | |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Pacira Pharmaceuticals Incorporated | $124.70 | 2023 | Iovera |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Nuvasive, INC. | $78.15 | 2019-2020 | |
| Boston Scientific Corporation | $29.45 | 2021 | |
| Medtronic USA, INC. | $23.08 | 2020 | |
| Abbott Laboratories | $19.75 | 2024 | Eterna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $15.83 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.